Results 41 to 50 of about 371,111 (371)
Immunogenicity of NS4b dengue 3 virus mimotope presented to the immune system as multiple antigen peptide system [PDF]
The availability of random peptide libraries displayed on bacteriophage (RPL) has provided a powerful tool for selecting sequences that mimic binding properties of natural antigen epitopes (mimotopes). These mimotopes can be used for vaccine design, drug
Acosta, Armando+11 more
core +2 more sources
Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study
INTRODUCTION: To analyze the liver dysfunction and evolution of signs and symptoms in adult dengue patients during a two-month follow-up period. METHODS: A prospective cohort study was conducted in Campos dos Goytacazes, Rio de Janeiro, Brazil, from ...
Ricardo Tristão-Sá+14 more
doaj +1 more source
Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication
Dengue fever is one of the most common viral infections affecting humans. It is an expanding public health problem, particularly in tropical and subtropical regions.
Kingshuk Panda+2 more
doaj +1 more source
Theoretical impact of insecticide-impregnated school uniforms on dengue incidence in Thai children. [PDF]
BACKGROUND: Children carry the main burden of morbidity and mortality caused by dengue. Children spend a considerable amount of their day at school; hence strategies that reduce human-mosquito contact to protect against the day-biting habits of Aedes ...
Amaku, Marcos+4 more
core +2 more sources
Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection
The antibody response during infection with dengue virus is a key component involved in the pathogenesis during secondary infection. Here the authors show antibodies targeting NS1 and the epitopes targeted can be associated with disease severity during ...
Deshni Jayathilaka+10 more
doaj +1 more source
Dengue Hemorrhagic Fever (DHF) is a global health problem in tropical and subtropical regions, as well as endemic in110 countries around the world. Indonesia is one of the largest countries in the region of endemic dengue.
Arif Ansori+6 more
doaj +1 more source
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
In order to support vaccine development, and to aid convalescent plasma therapy, it would be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing antibodies (NAbs), and their association with clinical disease severity ...
Chandima Jeewandara+12 more
doaj +1 more source
Drug repurposing approach against chikungunya virus: an in vitro and in silico study
The chikungunya virus (CHIKV) is an alphavirus transmitted by Aedes mosquitoes. There are no licenced antivirals or vaccines for treatment or prevention. Drug repurposing approach has emerged as a novel concept to find alternative uses of therapeutics to
Bhagyashri Kasabe+8 more
doaj +1 more source
Optimization of Dengue Epidemics: a test case with different discretization schemes [PDF]
The incidence of Dengue epidemiologic disease has grown in recent decades. In this paper an application of optimal control in Dengue epidemics is presented.
Ch. Tsitouras+5 more
core +2 more sources
Background Dengue infections have become a huge threat to public health systems in developing countries. Data on seroprevalence and incidence of dengue infections are lacking from rural regions of India.
Paresh S. Shah+8 more
doaj +1 more source